Skip to content
stoqly

Albemarle

ALB NYSE Specialty Chemicals Financials FY2016–FY2025

Albemarle's revenue fell 4.4% to $5.1 billion in fiscal 2025. Its operating margin was −7.1%, up from −33.0% a year earlier. Free cash flow was $692 million. It paid out $191 million in dividends and buybacks, 28% of free cash flow. The diluted share count rose 0.1%.

Last close · Oct 23, 2026

$93.67

1.2%
Value it Compare
Revenue Total sales reported in the income statement.
$5.1B
4.4% vs prior year
Operating margin Operating income as a share of revenue.
−7.1%
25.9 pts
Net income Profit after all expenses, interest and tax.
−$511M
Free cash flow Cash from operations minus capital spending.
$692M
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
−2.4%
8.5 pts
Market cap Last close times the latest diluted share count, so it is approximate.
$12.8B
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
—
On $0.26 EPS (TTM)

What Albemarle does

No business description yet.

Legal name
ALBEMARLE CORPORATION
Fiscal year ends
December 31, 2025
Latest annual report
—
Accession · CIK
0000915913-26-000018
0000915913

Revenue and margins

Albemarle had $5.1B of revenue in fiscal 2025, down 4.4% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $692M in fiscal 2025, 13.5% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Albemarle returned $191M to shareholders in fiscal 2025, 28% of free cash flow. The diluted share count rose 0.1%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Value Albemarle yourself

Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.

Discounted cash flow

Value per share

—

Adds net cash of −$1.7B and divides by 117.7M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.

Earnings multiple

Value per share

—

Reference multiples: today — · peers 19.1x · sector 20.4x.

Balance sheet

Cash, debt and the ratios that show how comfortably Albemarle can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $439M$1.5B$890M$1.2B$1.6B
Debt incl. finance leases $2.5B$3.3B$4.3B$3.6B$3.3B
Net debt / EBITDA 1.9x0.7x5.0x—5.8x
Debt / equity 0.4x0.4x0.5x0.4x0.4x
Interest coverage 13.0x20.1x2.2x−10.7x−1.8x
Current ratio 1.1x1.9x1.5x2.0x2.2x
Quick ratio 0.6x1.1x0.9x1.2x1.6x
Total assets $11.0B$15.5B$18.3B$16.6B$16.4B
Total liabilities $5.2B$7.3B$8.6B$6.4B$6.6B
Shareholders' equity $5.6B$8.0B$9.4B$10.0B$9.5B
Net debt (− = net cash) $2.0B$1.8B$3.4B$2.4B$1.7B

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$7.4M

3 insiders

Of sales under plans

0%

$0.0M

DateInsiderTradeSharesPriceValueFiling
May 15, 2026 Masters J KentChairman & CEO, Director Sold 16,393 $183.72 $3.0M Form 4
Mar 10, 2026 Masters J KentChairman & CEO, Director Sold 11,783 $170.81 $2.0M Form 4
Feb 20, 2026 Eric NorrisChief Commercial Officer Sold 5,692 $165.45 $0.9M Form 4
Feb 13, 2026 Melissa H. AndersonChief Bus..Transformation Off. Sold 8,454 $163.71 $1.4M Form 4
Oct 24, 2025 Ander C. KrupaGeneral Counsel & Sec Sold plan 172 $105.00 $0.0M Form 4

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY23FY24FY25
Net income is positive ✓ ✕ ✕
Cash from operations is positive ✓ ✓ ✓
Return on assets rose ✕ ✕ ✓
Cash from operations exceeds net income ✕ ✓ ✓
Debt fell relative to assets ✕ ✓ ✓
Current ratio rose ✕ ✓ ✓
Share count didn't rise ✓ ✓ ✕
Gross margin rose ✕ ✕ ✓
Revenue rose relative to assets ✕ ✕ ✓
F-score 3 / 95 / 97 / 9
Accruals ratio 1.5%−10.7%−10.9%
Altman Z'' 3.112.773.21

Similar companies

Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.

CompanyMarket capGrowthOp. marginFCF marginROICP/EF-score
Albemarle ALB $12.8B −4.4% −7.1% 13.5% −2.4% — 7
Axalta AXTA $7.3B −3.0% 14.4% 8.9% 10.5% 20.0x 7 Compare →
Solstice Advanced Materials SOLS $9.5B 3.1% — 3.1% 12.2% 39.9x — Compare →
H.B. Fuller FUL $2.7B −2.7% — 3.5% 6.3% 13.8x 7 Compare →
RPM International RPM $12.6B 6.7% — 8.6% 13.9% 18.3x 6 Compare →

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $2.7B $3.1B $3.4B $3.6B $3.1B $3.3B $7.3B $9.6B $5.4B $5.1B
Gross profit $970M $1.1B $1.2B $1.3B $995M $998M $3.1B $1.2B $62.5M $669M
Research and development $80.5M $84.3M $70.1M $58.3M $59.2M $54.0M $72.0M $85.7M $86.7M $51.4M
Operating income $601M $572M $912M $666M $506M $798M $2.5B $252M −$1.8B −$367M
Interest expense $65.2M $115M $52.4M $57.7M $73.1M $61.5M $123M $116M $166M $208M
Pretax income $515M $447M $795M $563M $374M $134M $2.4B $247M −$1.8B −$552M
Income tax $96.3M $432M $145M $88.2M $54.4M $29.4M $391M $430M $87.1M $157M
Net income $644M $54.8M $694M $533M $376M $124M $2.7B $1.6B −$1.2B −$511M
Diluted EPS $5.68 $0.49 $6.34 $5.02 $3.52 $1.06 $22.84 $13.36 −$11.20 −$5.76
Diluted shares 0.11B 0.11B 0.11B 0.11B 0.11B 0.12B 0.12B 0.12B 0.12B 0.12B
Cash flow
Cash from operations $736M $304M $546M $719M $799M $344M $1.9B $1.3B $688M $1.3B
Capital expenditure $197M $318M $700M $852M $851M $954M $1.3B $2.2B $1.7B $590M
Free cash flow $539M −$13.7M −$154M −$132M −$51.6M −$609M $646M −$828M −$993M $692M
Depreciation and amortization $226M $197M $201M $214M $232M $254M $301M $430M $589M $659M
Stock-based compensation $17.0M $19.4M $15.2M $19.7M $22.8M $20.1M $30.5M $36.5M $32.1M $40.3M
Acquisitions $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Share buybacks $0.0M $250M $500M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Dividends paid $135M $141M $145M $152M $162M $178M $184M $187M $189M $191M
Dividends and buybacks $135M $391M $645M $152M $162M $178M $184M $187M $189M $191M
Balance sheet
Cash and short-term investments $2.3B $1.1B $555M $613M $747M $439M $1.5B $890M $1.2B $1.6B
Total debt $2.4B $1.8B $1.7B $3.1B $3.6B $2.4B $3.2B $4.2B $3.5B $3.2B
Finance lease liabilities $0.0M $0.0M $0.0M $59.5M $60.3M $77.8M $79.4M $114M $119M $107M
Current assets $3.3B $2.5B $2.0B $2.2B $2.2B $2.0B $5.2B $5.2B $3.8B $4.0B
Current liabilities $1.1B $1.2B $1.2B $1.4B $1.8B $1.9B $2.7B $3.6B $2.0B $1.8B
Inventory $450M $593M $701M $769M $750M $799M $2.1B $2.2B $1.5B $1.2B
Property and equipment, net $2.4B $2.5B $3.0B $4.9B $5.4B $5.9B $7.0B $9.5B $9.3B $8.6B
Total assets $8.2B $7.8B $7.6B $9.9B $10.5B $11.0B $15.5B $18.3B $16.6B $16.4B
Total liabilities $4.2B $3.9B $3.8B $5.8B $6.0B $5.2B $7.3B $8.6B $6.4B $6.6B
Shareholders' equity $3.8B $3.7B $3.6B $3.9B $4.3B $5.6B $8.0B $9.4B $10.0B $9.5B
Margins
Gross margin 36.2% 36.0% 36.1% 35.0% 31.8% 30.0% 42.0% 12.3% 1.2% 13.0%
Operating margin 22.5% 18.6% 27.0% 18.6% 16.2% 24.0% 33.7% 2.6% −33.0% −7.1%
EBITDA margin 30.9% 25.0% 33.0% 24.5% 23.6% 31.6% 37.9% 7.1% −22.1% 5.7%
Net margin 24.0% 1.8% 20.6% 14.9% 12.0% 3.7% 36.8% 16.4% −21.9% −9.9%
FCF margin 20.1% −0.5% −4.6% −3.7% −1.7% −18.3% 8.8% −8.6% −18.5% 13.5%
Returns
Return on capital — 6.7% 15.8% 9.8% 6.2% 8.2% 23.3% 1.1% −10.9% −2.4%
Return on capital employed 8.0% 8.4% 14.1% 9.0% 5.9% 9.0% 22.7% 1.8% −12.1% −2.5%
Return on equity 18.3% 1.5% 19.1% 14.2% 9.2% 2.5% 39.5% 18.1% −12.2% −5.2%
Return on assets 7.3% 0.7% 9.1% 6.1% 3.7% 1.2% 20.4% 9.3% −6.8% −3.1%
Growth
Revenue growth −5.3% 14.8% 9.9% 6.4% −12.8% 6.4% 120.0% 31.4% −44.1% −4.4%
Net income growth 92.2% −91.5% 1,164.5% −23.1% −29.5% −67.1% 2,075.0% −41.5% −175.0% —
EPS growth 89.3% −91.4% 1,193.9% −20.8% −29.9% −69.9% 2,054.7% −41.5% −183.8% —
FCF growth 304.7% −102.6% — — — — — −228.1% — —
Share count change 1.5% −0.8% −2.6% −2.9% 0.5% 9.1% 1.1% −0.0% −0.2% 0.1%
Financial health
Net debt / EBITDA 0.1x 0.9x 1.0x 2.8x 3.9x 1.9x 0.7x 5.0x — 5.8x
Debt / equity 0.6x 0.5x 0.5x 0.8x 0.9x 0.4x 0.4x 0.5x 0.4x 0.4x
Interest coverage 9.2x 5.0x 17.4x 11.6x 6.9x 13.0x 20.1x 2.2x −10.7x −1.8x
Current ratio 2.9x 2.1x 1.7x 1.6x 1.2x 1.1x 1.9x 1.5x 2.0x 2.2x
Quick ratio 2.5x 1.6x 1.1x 1.0x 0.8x 0.6x 1.1x 0.9x 1.2x 1.6x
Capital allocation
Capex / revenue 7.4% 10.3% 20.7% 23.7% 27.2% 28.7% 17.2% 22.4% 31.3% 11.5%
Stock comp / revenue 0.6% 0.6% 0.5% 0.6% 0.7% 0.6% 0.4% 0.4% 0.6% 0.8%
Payouts / FCF 25.1% — — — — — 28.5% — — 27.5%
Quality scores
Piotroski F-score — 6.0 7.0 5.0 3.0 5.0 6.0 3.0 5.0 7.0
Altman Z'' 4.1 3.5 3.7 2.7 2.4 2.7 4.5 3.1 2.8 3.2
Accruals ratio −1.0% −3.1% 1.9% −2.1% −4.2% −2.1% 5.9% 1.5% −10.7% −10.9%

Source: SEC EDGAR XBRL filings (CIK 0000915913). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move · ↵ to open